Skip to main content
Midas Edge

Replimune Group, Inc.

For the period ended Mar 31, 2026. Filed Jun 29, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2026 · Filed Jun 29, 2026

REPL$23.28+4.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 15. Exhibits and financial statement schedules

(a)1. Consolidated financial statements.

For a list of the consolidated financial statements included herein, see Index on page F-1 of this report.

  1. Financial statement schedules.

All required information is included in the financial statements or notes thereto.

  1. List of exhibits.

The documents listed in the exhibit index immediately preceding the signature page of this Annual Report on Form 10-K are incorporated by reference or are filed or furnished with this Annual Report on Form 10-K, in each case as indicated therein.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.